Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 3020 entries
Sorted by: Best Match Show Resources per page
Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.

Acta medica Iranica

Aghaei Meybodi HR, Hasanzad M, Larijani B.
PMID: 28282717
Acta Med Iran. 2017 Mar;55(3):166-174.

Type 2 diabetes mellitus (T2DM) is recognized as a public health problem and increasingly prevalent illness. Key elements of the guideline for diabetes care are based on evidence-based medicine approach and apply for population, not individuals. However, individualized care...

Cite
Aghaei Meybodi HR, Hasanzad M, Larijani B. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope. Acta Med Iran. 2017;55(3):166-174
Aghaei Meybodi, H. R., Hasanzad, M., & Larijani, B. (2017). Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope. Acta medica Iranica, 55(3), 166-174.
Aghaei Meybodi, Hamid Reza, et al. "Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope." Acta medica Iranica vol. 55,3 (2017): 166-174.
Aghaei Meybodi HR, Hasanzad M, Larijani B. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope. Acta Med Iran. 2017 Mar;55(3):166-174. PMID: 28282717.
Copy Download .nbib Format: NLM
Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes.

Diabetes care

Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE.
PMID: 27660123
Diabetes Care. 2016 Oct;39(10):1846. doi: 10.2337/dc16-er10.

No abstract available.

Cite
Gaziano JM, Cincotta AH, O'Connor CM, et al. Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes Care. 2016;39(10):1846doi: 10.2337/dc16-er10.
Gaziano, J. M., Cincotta, A. H., O'Connor, C. M., Ezrokhi, M., Rutty, D., Ma, Z. J., & Scranton, R. E. (2016). Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes care, 39(10), 1846. https://doi.org/10.2337/dc16-er10
Gaziano, J Michael, et al. "Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes." Diabetes care vol. 39,10 (2016): 1846. doi: https://doi.org/10.2337/dc16-er10
Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE. Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes Care. 2016 Oct;39(10):1846. doi: 10.2337/dc16-er10. PMID: 27660123; PMCID: PMC6908412.
Copy Download .nbib Format: NLM
Comment on Narayan. Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture. Diabetes Care 2016;39:653-663.

Diabetes care

Reaven G.
PMID: 27660126
Diabetes Care. 2016 Oct;39(10):e181. doi: 10.2337/dc16-1067.

No abstract available.

Cite
Reaven G. Comment on Narayan. Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture. Diabetes Care 2016;39:653-663. Diabetes Care. 2016;39(10):e181doi: 10.2337/dc16-1067.
Reaven, G. (2016). Comment on Narayan. Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture. Diabetes Care 2016;39:653-663. Diabetes care, 39(10), e181. https://doi.org/10.2337/dc16-1067
Reaven, Gerald. "Comment on Narayan. Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture. Diabetes Care 2016;39:653-663." Diabetes care vol. 39,10 (2016): e181. doi: https://doi.org/10.2337/dc16-1067
Reaven G. Comment on Narayan. Type 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture. Diabetes Care 2016;39:653-663. Diabetes Care. 2016 Oct;39(10):e181. doi: 10.2337/dc16-1067. PMID: 27660126.
Copy Download .nbib Format: NLM
Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India.

Diabetes care

Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V.
PMID: 27493133
Diabetes Care. 2016 Oct;39(10):e169-70. doi: 10.2337/dc16-0869. Epub 2016 Aug 04.

No abstract available.

Cite
Kleinman NJ, Shah A, Shah S, et al. Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India. Diabetes Care. 2016;39(10):e169-70doi: 10.2337/dc16-0869.
Kleinman, N. J., Shah, A., Shah, S., Phatak, S., & Viswanathan, V. (2016). Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India. Diabetes care, 39(10), e169-70. https://doi.org/10.2337/dc16-0869
Kleinman, Nora J, et al. "Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India." Diabetes care vol. 39,10 (2016): e169-70. doi: https://doi.org/10.2337/dc16-0869
Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Impact of the Gather mHealth System on A1C: Primary Results of a Multisite Randomized Clinical Trial Among People With Type 2 Diabetes in India. Diabetes Care. 2016 Oct;39(10):e169-70. doi: 10.2337/dc16-0869. Epub 2016 Aug 04. PMID: 27493133.
Copy Download .nbib Format: NLM
Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes.

Diabetes care

Weisman A, Rovinski R, Farooqi MA, Lovblom LE, Halpern EM, Boulet G, Eldelekli D, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZ, Perkins BA.
PMID: 27006509
Diabetes Care. 2016 May;39(5):e67-8. doi: 10.2337/dc16-0102. Epub 2016 Mar 22.

No abstract available.

Cite
Weisman A, Rovinski R, Farooqi MA, et al. Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes. Diabetes Care. 2016;39(5):e67-8doi: 10.2337/dc16-0102.
Weisman, A., Rovinski, R., Farooqi, M. A., Lovblom, L. E., Halpern, E. M., Boulet, G., Eldelekli, D., Keenan, H. A., Brent, M. H., Paul, N., Bril, V., Cherney, D. Z., & Perkins, B. A. (2016). Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes. Diabetes care, 39(5), e67-8. https://doi.org/10.2337/dc16-0102
Weisman, Alanna, et al. "Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes." Diabetes care vol. 39,5 (2016): e67-8. doi: https://doi.org/10.2337/dc16-0102
Weisman A, Rovinski R, Farooqi MA, Lovblom LE, Halpern EM, Boulet G, Eldelekli D, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZ, Perkins BA. Commonly Measured Clinical Variables Are Not Associated With Burden of Complications in Long-standing Type 1 Diabetes: Results From the Canadian Study of Longevity in Diabetes. Diabetes Care. 2016 May;39(5):e67-8. doi: 10.2337/dc16-0102. Epub 2016 Mar 22. PMID: 27006509.
Copy Download .nbib Format: NLM
Insulin-Induced Distant Site Lipoatrophy.

Diabetes care

Kondo A, Nakamura A, Takeuchi J, Miyoshi H, Atsumi T.
PMID: 28396362
Diabetes Care. 2017 Jun;40(6):e67-e68. doi: 10.2337/dc16-2385. Epub 2017 Apr 10.

No abstract available.

Cite
Kondo A, Nakamura A, Takeuchi J, et al. Insulin-Induced Distant Site Lipoatrophy. Diabetes Care. 2017;40(6):e67-e68doi: 10.2337/dc16-2385.
Kondo, A., Nakamura, A., Takeuchi, J., Miyoshi, H., & Atsumi, T. (2017). Insulin-Induced Distant Site Lipoatrophy. Diabetes care, 40(6), e67-e68. https://doi.org/10.2337/dc16-2385
Kondo, Aki, et al. "Insulin-Induced Distant Site Lipoatrophy." Diabetes care vol. 40,6 (2017): e67-e68. doi: https://doi.org/10.2337/dc16-2385
Kondo A, Nakamura A, Takeuchi J, Miyoshi H, Atsumi T. Insulin-Induced Distant Site Lipoatrophy. Diabetes Care. 2017 Jun;40(6):e67-e68. doi: 10.2337/dc16-2385. Epub 2017 Apr 10. PMID: 28396362.
Copy Download .nbib Format: NLM
Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102.

Diabetes care

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ, Maahs DM, Buckingham BA, Dassau E.
PMID: 28887408
Diabetes Care. 2017 Nov;40(11):1606. doi: 10.2337/dc17-er11a. Epub 2017 Sep 08.

No abstract available.

Cite
Forlenza GP, Deshpande S, Ly TT, et al. Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102. Diabetes Care. 2017;40(11):1606doi: 10.2337/dc17-er11a.
Forlenza, G. P., Deshpande, S., Ly, T. T., Howsmon, D. P., Cameron, F., Baysal, N., Mauritzen, E., Marcal, T., Towers, L., Bequette, B. W., Huyett, L. M., Pinsker, J. E., Gondhalekar, R., Doyle, F. J., Maahs, D. M., Buckingham, B. A., & Dassau, E. (2017). Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102. Diabetes care, 40(11), 1606. https://doi.org/10.2337/dc17-er11a
Forlenza, Gregory P, et al. "Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102." Diabetes care vol. 40,11 (2017): 1606. doi: https://doi.org/10.2337/dc17-er11a
Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ, Maahs DM, Buckingham BA, Dassau E. Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102. Diabetes Care. 2017 Nov;40(11):1606. doi: 10.2337/dc17-er11a. Epub 2017 Sep 08. PMID: 28887408; PMCID: PMC5652589.
Copy Download .nbib Format: NLM
It is unfair to say nurses don't provide adequate diabetes care.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Brewer C.
PMID: 26373518
Nurs Stand. 2015 Sep 16;30(3):31. doi: 10.7748/ns.30.3.31.s39.

No abstract available.

Cite
Brewer C. It is unfair to say nurses don't provide adequate diabetes care. Nurs Stand. 2015;30(3):31doi: 10.7748/ns.30.3.31.s39.
Brewer, C. (2015). It is unfair to say nurses don't provide adequate diabetes care. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 30(3), 31. https://doi.org/10.7748/ns.30.3.31.s39
Brewer, Clare. "It is unfair to say nurses don't provide adequate diabetes care." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 30,3 (2015): 31. doi: https://doi.org/10.7748/ns.30.3.31.s39
Brewer C. It is unfair to say nurses don't provide adequate diabetes care. Nurs Stand. 2015 Sep 16;30(3):31. doi: 10.7748/ns.30.3.31.s39. PMID: 26373518.
Copy Download .nbib Format: NLM
Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes.

Diabetes care

Gourgari EA, Mete M, Sampson ML, Harlan DM, Remaley AT, Rother KI.
PMID: 28515131
Diabetes Care. 2017 Jul;40(7):e88-e89. doi: 10.2337/dc16-2602. Epub 2017 May 17.

No abstract available.

Cite
Gourgari EA, Mete M, Sampson ML, et al. Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes. Diabetes Care. 2017;40(7):e88-e89doi: 10.2337/dc16-2602.
Gourgari, E. A., Mete, M., Sampson, M. L., Harlan, D. M., Remaley, A. T., & Rother, K. I. (2017). Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes. Diabetes care, 40(7), e88-e89. https://doi.org/10.2337/dc16-2602
Gourgari, Evgenia A, et al. "Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes." Diabetes care vol. 40,7 (2017): e88-e89. doi: https://doi.org/10.2337/dc16-2602
Gourgari EA, Mete M, Sampson ML, Harlan DM, Remaley AT, Rother KI. Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes. Diabetes Care. 2017 Jul;40(7):e88-e89. doi: 10.2337/dc16-2602. Epub 2017 May 17. PMID: 28515131; PMCID: PMC5481982.
Copy Download .nbib Format: NLM
Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035.

Diabetes care

Rosenstock J, Aronson R, Grunberger G, Hanefeld M, Piatti P, Serusclat P, Cheng X, Zhou T, Niemoeller E, Souhami E, Davies M.
PMID: 28420696
Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06c. Epub 2017 Apr 18.

No abstract available.

Cite
Rosenstock J, Aronson R, Grunberger G, et al. Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035. Diabetes Care. 2017;40(6):809doi: 10.2337/dc17-er06c.
Rosenstock, J., Aronson, R., Grunberger, G., Hanefeld, M., Piatti, P., Serusclat, P., Cheng, X., Zhou, T., Niemoeller, E., Souhami, E., Davies, M. (2017). Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035. Diabetes care, 40(6), 809. https://doi.org/10.2337/dc17-er06c
Rosenstock, Julio, et al. "Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035." Diabetes care vol. 40,6 (2017): 809. doi: https://doi.org/10.2337/dc17-er06c
Rosenstock J, Aronson R, Grunberger G, Hanefeld M, Piatti P, Serusclat P, Cheng X, Zhou T, Niemoeller E, Souhami E, Davies M. Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035. Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06c. Epub 2017 Apr 18. PMID: 28420696; PMCID: PMC5439410.
Copy Download .nbib Format: NLM
Type 1 diabetes at a crossroads!.

Diabetes care

Cefalu WT, Tamborlane WV, Skyler JS.
PMID: 25998288
Diabetes Care. 2015 Jun;38(6):968-70. doi: 10.2337/dc15-0615.

No abstract available.

Cite
Cefalu WT, Tamborlane WV, Skyler JS. Type 1 diabetes at a crossroads!. Diabetes Care. 2015;38(6):968-70doi: 10.2337/dc15-0615.
Cefalu, W. T., Tamborlane, W. V., & Skyler, J. S. (2015). Type 1 diabetes at a crossroads!. Diabetes care, 38(6), 968-70. https://doi.org/10.2337/dc15-0615
Cefalu, William T, et al. "Type 1 diabetes at a crossroads!." Diabetes care vol. 38,6 (2015): 968-70. doi: https://doi.org/10.2337/dc15-0615
Cefalu WT, Tamborlane WV, Skyler JS. Type 1 diabetes at a crossroads!. Diabetes Care. 2015 Jun;38(6):968-70. doi: 10.2337/dc15-0615. PMID: 25998288; PMCID: PMC5131855.
Copy Download .nbib Format: NLM
Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory".

Diabetes care

Cefalu WT, Rosenstock J, LeRoith D, Blonde L, Riddle MC.
PMID: 27208373
Diabetes Care. 2016 May;39(5):664-7. doi: 10.2337/dc16-0405.

No abstract available.

Cite
Cefalu WT, Rosenstock J, LeRoith D, et al. Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory". Diabetes Care. 2016;39(5):664-7doi: 10.2337/dc16-0405.
Cefalu, W. T., Rosenstock, J., LeRoith, D., Blonde, L., & Riddle, M. C. (2016). Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory". Diabetes care, 39(5), 664-7. https://doi.org/10.2337/dc16-0405
Cefalu, William T, et al. "Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory"." Diabetes care vol. 39,5 (2016): 664-7. doi: https://doi.org/10.2337/dc16-0405
Cefalu WT, Rosenstock J, LeRoith D, Blonde L, Riddle MC. Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory". Diabetes Care. 2016 May;39(5):664-7. doi: 10.2337/dc16-0405. PMID: 27208373; PMCID: PMC5013718.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 3020 entries